Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Rocket Pharmaceuticals
RCKT
$373M
| $14.3M | ﹤0.01% |
532,563
+7,111
| +1% | +$202K |
|
1802
AdaptHealth
AHCO
$1.51B
| $14.3M | ﹤0.01% |
1,244,766
+203,819
| +20% | +$1.73M |
|
1803
Agilysys
AGYS
$3.08B
| $14.3M | ﹤0.01% |
169,927
+1,063
| +0.6% | +$85.9K |
|
1804
ProPetro Holding
PUMP
$1.36B
| $14.3M | ﹤0.01% |
1,770,017
+83,802
| +5% | +$654K |
|
1805
Sturm, Ruger & Co
RGR
$617M
| $14.3M | ﹤0.01% |
309,627
-256,983
| -45% | -$11.4M |
|
1806
Immunovant
IMVT
$7.9B
| $14.3M | ﹤0.01% |
442,084
+5,004
| +1% | +$183K |
|
1807
Matthews International
MATW
$889M
| $14.3M | ﹤0.01% |
459,491
+29,009
| +7% | +$897K |
|
1808
Clear Secure
YOU
$5.55B
| $14.3M | ﹤0.01% |
670,874
+15,907
| +2% | +$316K |
|
|
ATSG
1809
DELISTED
Air Transport Services Group
ATSG
| $14.2M | ﹤0.01% |
1,034,571
+117,747
| +13% | +$1.7M |
|
1810
Kymera Therapeutics
KYMR
$8.29B
| $14.2M | ﹤0.01% |
354,106
+47,414
| +15% | +$1.7M |
|
|
NVEE
1811
DELISTED
NV5 Global
NVEE
| $14.2M | ﹤0.01% |
578,540
+29,396
| +5% | +$763K |
|
1812
Innoviva
INVA
$1.53B
| $14.2M | ﹤0.01% |
928,663
-4,596
| -0.5% | -$72.2K |
|
1813
John B. Sanfilippo & Son
JBSS
$991M
| $14.1M | ﹤0.01% |
133,284
+3,212
| +2% | +$331K |
|
|
VBTX
1814
DELISTED
Veritex Holdings
VBTX
| $14.1M | ﹤0.01% |
685,960
+38,474
| +6% | +$796K |
|
1815
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.6B
| $14M | ﹤0.01% |
470,734
-74,443
| -14% | -$2.21M |
|
|
RNAM
1816
DELISTED
Avidity Biosciences
RNAM
| $14M | ﹤0.01% |
548,435
+2,664
| +0.5% | +$41.7K |
|
1817
Zeta Global
ZETA
$5.59B
| $13.9M | ﹤0.01% |
1,269,993
+20,634
| +2% | +$206K |
|
1818
AdvanSix
ASIX
$541M
| $13.8M | ﹤0.01% |
483,570
+46,177
| +11% | +$1.23M |
|
1819
Forward Air
FWRD
$455M
| $13.8M | ﹤0.01% |
443,433
+86,512
| +24% | +$3.62M |
|
1820
SFL Corp
SFL
$1.64B
| $13.8M | ﹤0.01% |
1,044,754
-9,593
| -0.9% | -$121K |
|
1821
Keros Therapeutics
KROS
$198M
| $13.8M | ﹤0.01% |
207,758
+26,180
| +14% | +$1.55M |
|
1822
Sotera Health
SHC
$5.14B
| $13.7M | ﹤0.01% |
1,143,846
+245,526
| +27% | +$3.65M |
|
1823
Conduent
CNDT
$265M
| $13.7M | ﹤0.01% |
4,059,559
+79,947
| +2% | +$278K |
|
1824
Acco Brands
ACCO
$405M
| $13.7M | ﹤0.01% |
2,440,923
+18,900
| +0.8% | +$112K |
|
1825
Hayward Holdings
HAYW
$3.28B
| $13.6M | ﹤0.01% |
890,248
+163,580
| +23% | +$2.19M |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.